US Patent Issued to SECOND AFFILIATED HOSPITAL, SECOND MILITARY MEDICAL UNIVERSITY on Aug. 26 for "Application of 5-hydroxytryptamine receptor 1A in preparing drug for portal hypertension" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,990, issued on Aug. 26, was assigned to SECOND AFFILIATED HOSPITAL, SECOND MILITARY MEDICAL UNIVERSITY (Shanghai).

"Application of 5-hydroxytryptamine receptor 1A in preparing drug for portal hypertension" was invented by Wei-Fen Xie (Shanghai), Chang-Peng Zhu (Shanghai) and Xin Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the technical field of pharmaceuticals and specifically describes an application of a 5-hydroxytryptamine receptor 1A in preparing a drug for portal hypertension. The present invention achieved a significant decrease in portal venous pressure in model rats with cirrhotic portal hy...